These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 9106464
21. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice. Fuchs PN, Roza C, Sora I, Uhl G, Raja SN. Brain Res; 1999 Mar 13; 821(2):480-6. PubMed ID: 10064835 [Abstract] [Full Text] [Related]
27. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior. Wang YJ, Tao YM, Li FY, Wang YH, Xu XJ, Chen J, Cao YL, Chi ZQ, Neumeyer JL, Zhang A, Liu JG. J Pharmacol Exp Ther; 2009 Apr 13; 329(1):306-13. PubMed ID: 19136637 [Abstract] [Full Text] [Related]
28. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus. Garaulet JV, Laorden ML, Milanés MV. J Pharmacol Exp Ther; 1994 Jun 13; 269(3):993-9. PubMed ID: 8014886 [Abstract] [Full Text] [Related]
29. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists. Murray CW, Cowan A. J Pharmacol Exp Ther; 1991 Apr 13; 257(1):335-41. PubMed ID: 1850470 [Abstract] [Full Text] [Related]
31. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine. Randich A, Robertson JD, Willingham T. Brain Res; 1993 Feb 19; 603(2):186-200. PubMed ID: 8096421 [Abstract] [Full Text] [Related]
34. In vivo treatment with mu and delta, but not kappa-selective opioid agonists reduces [3H]spiperone binding to the guinea-pig striatum: autoradiographic evidence. Brent PJ, Bunn SJ. Brain Res; 1994 Aug 22; 654(2):191-9. PubMed ID: 7987668 [Abstract] [Full Text] [Related]
35. Intrathecally injected nicotine enhances the antinociception induced by morphine but not beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intrathecally in the mouse. Suh HW, Song DK, Lee KJ, Choi SR, Kim YH. Neuropeptides; 1996 Aug 22; 30(4):373-8. PubMed ID: 8914864 [Abstract] [Full Text] [Related]
37. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse. Tseng LF, Collins KA, Kampine JP. Eur J Pharmacol; 1994 Jun 02; 258(1-2):R1-3. PubMed ID: 7925585 [Abstract] [Full Text] [Related]
38. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Takahashi M, Senda T, Kaneto H. Eur J Pharmacol; 1991 Aug 06; 200(2-3):293-7. PubMed ID: 1664330 [Abstract] [Full Text] [Related]